000 02742nam a2200265Ia 4500
008 231030s9999 xx 000 0 und d
049 _aDeposit
082 _a617.6342
097 _aM.Sc
099 _aCai01.09.08.M.Sc.2021.Mo.P
100 _aMohamed Abd El basset Mustafa Mohamed Sleem,
245 _aPrevalence of oral mucosal alterations in a sample of Egyptian patients with cardiovascular diseases :
_bA hospital based cross-sectional study /
_cby Mohamed Abd El basset Mustafa Mohamed Sleem ; Supervisors Weam Ahmed Maher Rashawn, Noha Hassanin Mohamed.
246 _aنسب التغير في الغشاء الفموى بالمرضي المصريين المصابين بامراض القلب والاوعيه الدمويه : دراسة مقطعية
260 _c2021.
502 _aThesis (M.Sc.)-Cairo University,2021.
504 _aBibliography: p. 97-102.
520 _aAim: The aim of the current study was to determine the prevalence of oral mucosal alterations in cardiovascular patients TREATED FOR CARDIOVASCULAR DISEASDES and to investigate the presence of a possible relation between different cardiovascular diseases, drugs and oral manifestations. Methodology: Three hundred and thirty-eight adult patients had diagnosed with cardiovascular diseases at Kasr Al-Einy Hospital, Faculty of Medicine, Cairo University, were exanimated for oral signs and symptoms as oral dryness, dysphagia and burning sensation. The patients were also clinically examined to report any oral lesions in oral mucosa such as lichenoid reactions, xerostomia, and gingival enlargements. Results: Oral manifestations were recorded in 253 (74.8%) patients as adverse effect to cardiovascular drugs. The most common manifestation was gingival overgrowth (50.3%),followed by xerostomia (40%), burning sensation (21%) ,dysphagia (10.65%), and lichenoid reaction (1.47%). The drugs found to most commonly cause xerostomia were combination of NGDs + antiplatelet, congestive heart failure drugs, beta blocker and BBDs +diuretics, while the most common to cause burning sensation were CCBs+ antiplatelet and Congestive heart failure drugs. The most known cause of gingival over growth was calcium channel blocker drugs.Conclusions: Patients who are being treated for a cardiovascular illness will almost always experience an adverse oral event such as xerostomia, burning sensation or gingival overgrowth. Concomitant symptomatic oral care should be provided to these patients to better their quality of life.
650 _aDentistry
700 _aWeam Ahmed Maher Rashawn
905 _aMohamady
942 _cTH
_2ddc
999 _c165358
_d165358
336 _2rda content
_atext
337 _2rdamedia
_aUnmediated
338 _2rdacarrier
_avolume